Entera Bio reveals data for oral GLP-2 peptide for short bowel syndrome patients
Entera Bio has revealed positive pharmacokinetic results from its collaborative research combining a proprietary long acting GLP-2...
top of page
Browse by category
Search
Browse by tag
bottom of page